23
Nov
2026

Divis Laboratories Limited

Exhibitor at CPHI India 2026 stand 2J38
About Us

Divi’s Laboratories Limited, established in 1990, is among the world’s largest API manufacturers with ~$1.2B in revenue and exports to 100+ countries. We specialize in generic APIs, nutraceutical ingredients, and custom synthesis of APIs & intermediates for global innovators, primarily serving regulated markets in the US and Europe. 

With 3 state-of-the-art facilities, a presence across key geographies, and a 20,000+ strong team, Divi’s is committed to sustainable, innovative, and reliable manufacturing.

  • Country/Region:
    India
  • Founded:
    1990
  • On CPHI since:
    2015
  • Certificates:
    4
  • Employees:
    5000+
Company types
CMO/CDMO
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Primary activities
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Generic APIs producer
Contact info
Event information
CPHI India 2026
  • 23 Nov 2026 - 25 Nov 2026
  • IICC, Yashobhoomi, Dwarka, Delhi
  • Visit us at stand 2J38

Products Featured at CPHI India 2026

  • API Contract manufacturing/CDMO/CMO

    Product API Contract manufacturing/CDMO/CMO

    Small Molecules, HPAPIs, Peptides, Biological Buffers
  • Irbesartan

    Product Irbesartan

    Divis provides a wide range of generic API's which includes Irbesartan. Contact us for more information.
  • Dextromethorphan Base

    Product Dextromethorphan Base

    Divis provides a wide range of generic API's which includes dextromethorphan base. Contact us for more information.
  • Levetiracetam

    Product Levetiracetam

    Divis provides a wide range of generic API's which includes levetiracetam. Contact us for more information.